Michael Burgess actually said...

"The FDA always looks to whether things are safe and effective, well, with the exception of tobacco."

"I think that is one of the reasons these committee hearings have been so important."

"I do think that ONC has a unique perspective on these HIT issues, and along with input from the FDA and from stakeholders that Congress can find a path forward on what a framework would look like."

"Inaction is not an option on this issue. However, we must do so in a way that encourages the development of innovative technologies."